Eagle Pharmaceuticals Inc Sustainability Reports
Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing injectable products, primarily in the areas of critical care and oncology. The company leverages regulatory paths like the 505(b)(2) process to develop advanced formulations of existing medicines.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 549300TN20OLYTJVP152
FIGI: BBG005Y3XXX9
2 reports from 2022 to 2024
